Literature DB >> 10101983

Barriers to follow-up of abnormal Papanicolaou smears in an urban community health center.

M D McKee1, J Lurio, P Marantz, W Burton, M Mulvihill.   

Abstract

OBJECTIVE: To determine factors predictive of failure to return for colposcopy among women with significant abnormalities on Papanicolaou smears in a high-risk clinical population.
DESIGN: Telephone survey.
SETTING: An urban community health center. PARTICIPANTS: Two hundred seventy-nine women randomly selected from all women seen at the health center with abnormal Papanicolaou smears requiring colposcopy during 1993 to 1994. Six (2%) refused participation, and 19% could not be reached for inclusion. Subjects were mostly minority women receiving Medicaid. MAIN OUTCOME MEASURE: Completion of colposcopy.
RESULTS: Of the 279 selected women, 79% were interviewed. The rate of adherence with colposcopy was 75% for the respondents. Women who did not know the results of their smear or who incorrectly understood their results were significantly less likely to return for colposcopy (P = .001). Younger women, especially teenagers, were less likely to return (P = .02). Socioeconomic status, education, primary language, health beliefs, fear of cancer, and clinician's gender or discipline were not associated with rate of follow-up. Barriers involving transportation, child care, and insurance also did not predict follow-up.
CONCLUSIONS: Effective communication of results is the most important factor related to follow-up after abnormal Papanicolaou smear in this setting. In other settings, other factors may be of greater importance.

Entities:  

Mesh:

Year:  1999        PMID: 10101983     DOI: 10.1001/archfami.8.2.129

Source DB:  PubMed          Journal:  Arch Fam Med        ISSN: 1063-3987


  19 in total

1.  Factors associated with time to colposcopy after abnormal Pap testing in HIV-infected women.

Authors:  Amy S Baranoski; Elizabeth A Stier
Journal:  J Womens Health (Larchmt)       Date:  2011-12-05       Impact factor: 2.681

2.  Inadequate follow-up for abnormal Pap smears in an urban population.

Authors:  Neeraja B Peterson; Jini Han; Karen M Freund
Journal:  J Natl Med Assoc       Date:  2003-09       Impact factor: 1.798

Review 3.  Interventions to improve follow-up of abnormal findings in cancer screening.

Authors:  Roshan Bastani; K Robin Yabroff; Ronald E Myers; Beth Glenn
Journal:  Cancer       Date:  2004-09-01       Impact factor: 6.860

Review 4.  Social, prognostic, and therapeutic factors associated with cancer survival: a population-based study in metropolitan Detroit, Michigan.

Authors:  Kevin M Gorey; Eric J Holowaty; Ethan Laukkanen; Isaac N Luginaah
Journal:  J Health Care Poor Underserved       Date:  2003-11

5.  Using the word 'cancer' in communication about an abnormal Pap test: finding common ground with patient-provider communication.

Authors:  Melissa A Simon; Ludmila Cofta-Woerpel; Veenu Randhawa; Priya John; Gregory Makoul; Bonnie Spring
Journal:  Patient Educ Couns       Date:  2010-01-08

6.  Inconsistencies between medical records and patient-reported recommendations for follow-up after abnormal Pap tests.

Authors:  Stacey Slone; Carol White; Brent Shelton; Emily Van Meter; Christopher DeSimone; Nancy Schoenberg; Mark Dignan
Journal:  J Womens Health (Larchmt)       Date:  2012-11-12       Impact factor: 2.681

7.  Evaluating the stage of change model to a cervical cancer screening intervention among Ohio Appalachian women.

Authors:  Jessica L Krok-Schoen; Jill M Oliveri; Gregory S Young; Mira L Katz; Cathy M Tatum; Electra D Paskett
Journal:  Women Health       Date:  2015-10-19

8.  Invasive cervical cancer risk among HIV-infected women: a North American multicohort collaboration prospective study.

Authors:  Alison G Abraham; Gypsyamber D'Souza; Yuezhou Jing; Stephen J Gange; Timothy R Sterling; Michael J Silverberg; Michael S Saag; Sean B Rourke; Anita Rachlis; Sonia Napravnik; Richard D Moore; Marina B Klein; Mari M Kitahata; Gregory D Kirk; Robert S Hogg; Nancy A Hessol; James J Goedert; M John Gill; Kelly A Gebo; Joseph J Eron; Eric A Engels; Robert Dubrow; Heidi M Crane; John T Brooks; Ronald J Bosch; Howard D Strickler
Journal:  J Acquir Immune Defic Syndr       Date:  2013-04-01       Impact factor: 3.731

9.  ACCISS study rationale and design: activating collaborative cancer information service support for cervical cancer screening.

Authors:  Ludmila Cofta-Woerpel; Veenu Randhawa; H Gene McFadden; Angela Fought; Emily Bullard; Bonnie Spring
Journal:  BMC Public Health       Date:  2009-12-02       Impact factor: 3.295

10.  Effect of health beliefs on delays in care for abnormal cervical cytology in a multi-ethnic population.

Authors:  Karin Nelson; Ann M Geiger; Carol M Mangione
Journal:  J Gen Intern Med       Date:  2002-09       Impact factor: 5.128

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.